Story perspectives

GLP-1 Medications: 11% Higher Fracture Risk in Seniors

3/8/2026

Summary

Story summary

Glucagon-like peptide-1 (GLP-1) medications Ozempic and Wegovy may raise fracture risk in older adults with type 2 diabetes, showing an 11% higher risk versus other treatments.
Over five years, users showed a 29% higher risk of osteoporosis.
Experts say rapid weight loss from these medications may reduce bone density.
Despite concerns, these medications are effective for blood sugar control and weight loss, and nutrition and resistance training mitigate risks.

1 of 1

Story summary

Glucagon-like peptide-1 (GLP-1) medications Ozempic and Wegovy may raise fracture risk in older adults with type 2 diabetes, showing an 11% higher risk versus other treatments.
Over five years, users showed a 29% higher risk of osteoporosis.
Experts say rapid weight loss from these medications may reduce bone density.
Despite concerns, these medications are effective for blood sugar control and weight loss, and nutrition and resistance training mitigate risks.